CYGNOS BIOTECH, LLC

MIAMI, FL, 33176

Unclaimed

Prime contracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

Role	Agency	Description	Vehicle	Obligated	Action date	Period
Prime	Department of Defense Department of the Army	THE PURPOSE OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II CONTRACT IS TO SHOW EFFICACY OF ANTI-VIRAL TREATMENT WITH THE PVX THERAPEUTIC. W911SR26CA003USAspending	—	$1,397,164	May 15, 2026	Feb 2, 2026 – Aug 1, 2027

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

Department of DefenseGov-sourced

Is this your company?

Claim this profile for free to add your capabilities, teaming interests, capability statement link and employee count, and to report certifications for verification.

FedSub reviews every claim before granting access. Government-sourced data stays as published; your additions are labeled company-reported.

Claim this profile (free)

Identifiers

UEI: PXYDY5CQJDM3
CAGE: 8WQ76
Website: www.cygnosbiotech.com

NAICS codes

541714Research and Development in Biotechnology (except Nanobiotechnology)Primary(definition)

Data sources

SAM.gov monthly extract
ID PXYDY5CQJDM3 · fetched Oct 25, 2026 · source
USAspending.gov
ID recipient:PXYDY5CQJDM3 · fetched Oct 25, 2026 · source

Last synced Oct 25, 2026 · profile updated Oct 25, 2026

Find similar contractors

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.